RxDoctor Payments Data

Max Root, MD

Physical Medicine & Rehabilitation · St George, UTNPI 1295725380

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Boston Scientific at 47.7% of the total. Reporting peaked in 2024 at $141 and has fallen 70.8% since, to $41 in 2025.

$471in general payments, 2019–2025

Across 19 payments — averaging $24.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$225
  • AbbVie$150
  • Indivior Inc.$31
  • Medtronic$31
  • Nevro Corp.$19
  • Teva Pharmaceuticals USA, Inc.$16

What the payments were for

  • Food & beverage$471100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific8$225
AbbVie6$150
Indivior Inc.1$31
Medtronic(2 entities)2$31
Nevro Corp.1$19
Teva Pharmaceuticals USA, Inc.1$16

How this compares

$471 in reported general payments places this provider in the 60th percentile of 117 physical medicine & rehabilitation providers in Utah.

See all physical medicine & rehabilitation providers in Utah

Medicare billing

Part B allowed, 2024
$108,882
Medicare patients
188
Services billed
1,515

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen577$15,151
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl36$8,816
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen225$7,286
Buprenorphine28$6,537
Oxycodone Hcl261$5,135
Buprenorphine Hcl29$2,516
Tramadol Hcl120$2,025
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine23$1,456
Morphine Sulfate ErMorphine Sulfate47$1,277
Fentanyl14$870
Ondansetron OdtOndansetron30$744
Methadone Hcl27$669
Gabapentin87$656
Ondansetron Hcl16$575
Pregabalin55$501

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in St George

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →